Latest News Archive

Please select Category, Year, and then Month to display items

UFS researchers using mushrooms to clean contaminated water

28 August 2024 | Story André Damons | Photo Supplied

In an effort to alleviate the burden of water contamination, Prof Patricks Voua Otomo, Associate Professor in the Department of Zoology and Entomology at the University of the Free (UFS) is researching how mushrooms can be used to significantly reduce the toxicity of water.

The degradation of river systems in South Africa has been linked primarily to the inability of municipalities to properly treat wastewater. According to the 2022 Green Drop Report, out of the existing 850 wastewater systems across 90 municipalities, only 23 (or less than 3%) qualified for the Green Drop Certification. This underscores the depth and breadth of the wastewater treatment crisis in South Africa and its potential implications for human and environmental health.

In 2030, billions of people will still lack access to safe water, sanitation and hygiene services – the most basic human need for health and well-being. Target 6.1 of the United Nations (UN) Sustainable Development Goals (SDGs) – SDG 6 – aims to achieve universal and equitable access to safe and affordable drinking water for all, while target 6.3 is also looking to improve water quality by reducing pollution, eliminating dumping and minimising release of hazardous chemicals and materials, halving the proportion of untreated wastewater and substantially increasing recycling and safe re-use globally by 2030.

These challenges inform Prof Voua Otomo’s research, which focuses on the drivers of river pollution in the Qwaqwa region, ways to mitigate/remediate their effects, and the development of simple and quick methods to assess water quality. His research, which is part of the UFS 2023 Impact Report, has drawn attention to localised incidences of terrestrial and aquatic contamination linked to sewage sludge management by local wastewater treatment plants.

Using mycofiltration to reclaim the quality of contaminated water

In Qwaqwa, wastewater treatment plants, however, are not the only source of river pollution, as a significant amount of river pollutants emanates directly from the communities that often dispose of their household waste directly into the waterways. This has led to unacceptable levels of pharmaceuticals such as biphenyl-4-ylacetic acid (an anti-inflammatory), efavirenz (an HIV medicine), and carbamazepine (an epilepsy medicine) ending up in rivers.

To attempt to reclaim the quality of contaminated water, ongoing research in Prof Voua Otomo’s laboratory involves the use of ‘mycofiltration’, i.e., the use of fungal mycelia for the purpose of water filtration. This relatively untapped eco-friendly technology is attracting more attention, yet its real merits are only now being established and documented scientifically.

“Various species of fungi have been explored in bioremediation studies, and those belonging to the Pleurotus genus (edible mushrooms) have demonstrated an exceptional ability in the biosorption of contaminants,” says Prof Voua Otomo.

In his field of research, Prof Voua Otomo says snails can be used as bioindicators (i.e., organisms used to assess the health of an environment or ecosystem, particularly by indicating the presence and impact of pollutants or other environmental stressors) or biomonitors (i.e., organisms or a biological systems used to assess the health of an environment, particularly by detecting changes in the levels of pollutants or other harmful substances).

“We designed a mycofilter made of mycelia from the mushroom species Pleurotus ostreatus and filtrated water contaminated with the organic insecticide imidacloprid and the inorganic chemical iron (III). The results showed that mycofiltration could remove up to 94% of iron (III) and 31% of imidacloprid.

“Mycofiltration works through a process called adsorption, which is the process where molecules, ions, or particles from a gas, liquid, or dissolved solid, stick to a surface. This happens when the adsorbate (the substance being adsorbed) attaches to the adsorbent (the surface it adheres to),” Prof Voua Otomo explains.

Mycofiltration viable and affordable for water remediation

This research is the brainchild of Sanele Mnkandla, a final-year PhD student in Prof Voua Otomo’s laboratory. “A few years ago, she suggested looking at mycofiltration as a means to improve the quality of contaminated water. Freshwater snails were the most suitable organisms to help assess the improvement of the water quality after mycofiltration,” explains Prof Voua Otomo.

According to him, they are currently exploring ways to upscale the mycofilter to improve the quality of larger bodies of water, including rivers. The duration of the process depends on the size of the filter, the amount of water to be filtered and the targeted chemicals. Bigger filters, explains Prof Voua Otomo, will filter larger amounts of water over a relatively longer time whereas smaller ones will be saturated quickly. The process could last from minutes to days.

“We have published a technical note on the topic and a proof of concept. We are currently testing this technology using wastewater effluent in the Qwaqwa region. We are also exploring local applications in rainwater harvesting.

“Mycofiltration is certainly a viable and affordable option for water remediation, which can find a wide range of applications in South Africa,” he says.

Watch the video below

Helisoma duryi freshwater snails exposed in non-mycofiltered ferric iron aqueous solution, mycofiltered ferric iron aqueous solution and tap water (control).

Mycofiltration of ferric iron aqueous solution.

Pleurotus ostreatus mycofilter. Thatching straw fully colonised by P. ostreatus mycelia (white).

News Archive

Conference: Expanded ARV treatment

2005-03-02

VENUE: University of the Free State, Bloemfontein, South Africa
DATE: 30 March 2005 - 1 April 2005

ARV Programme as on 24Feb Download Word document
Programme Special events Download Word document

Official web site www.fshealth.gov.za/subsites/arvc

Rationale for the Conference
At the time of the planned Conference, much ground would have been covered, both in the Free State and in South Africa, in respect of the expanded public sector ARV treatment programme in respect of research, experiences in practice, training of staff, treatment of patients, lessons learned, successes and failures, etc. The time would then be quite opportune to share these in a systematic manner with other provinces and countries, as well as with the large variety of stakeholders and role players in the ARV and related domains, be they academics and researchers, policy makers and service/facility managers, the variety of caregivers, and the community organisations and affected patients.

The Conference and current research
The proposed Conference is, firstly, directly linked to the current research on the public sector roll-out of ARV treatment in the Free State conducted by several research institutions (e.g. CIET, CHSR&D, UCT Lung Institute). Secondly, the Conference could and would serve as a forum for other research groups in the country and further a field to report and share knowledge and experiences on ARV treatment and related initiatives. Lastly, the Conference will stage a golden opportunity for researchers and scientists, on the one hand, and policy makers, managers, and caregivers (as knowledge users), on the other hand, to engage in cross-disciplinary discourse on this mutual and topical theme.

Theme of Conference
Expanded ARV treatment in the Free State: sharing experiences

Focus
The focus is primarily on public sector ARV treatment in the Free State, but also initiatives/activities/perspectives of relevance to the Free State elsewhere in the country at large and further a field, as well as relevant ARV initiatives in the public, private, NGO and FBO sectors. Bear in mind, however, that ARV treatment is but part of a much more comprehensive approach to HIV and AIDS. The Conference will, therefore, not narrowly focus on the ARV treatment programme only. The broader context, other relevant dimensions, and a comprehensive approach to the challenges of HIV, AIDS and TB are of equal importance.

The purpose of the Conference
Enhance meaningful exchange, mutual understanding and collaboration among researchers, scientists, policy makers, managers and practitioners in the field of ARV treatment and related fields.

Share experiences in the various spheres of ARV treatment and related spheres (policy, management, practice, research, training, public-private-civil society sectors).

Record, reflect and report on the establishment of the ARV treatment programme in the Free State, and in within the context of the comprehensive HIV/AIDS programme.

Disseminate important research results on ARV treatment and related themes to health policy makers, managers, practitioners, communities and to the research community.

Stimulate discourse among various disciplines and various stakeholders/role players involved in ARV treatment and related programmes.

Sensitise and acquaint researchers to the requirements of policy makers, managers and practitioners in respect of ARV treatment and related fields.

Facilitate the implementation of research results in ARV treatment policy, programmes and practice.

Dissemination of Conference-related information
Information generated during the Conference could feed into policy, management and practice of ARV treatment, the training accompanying such programme, and the existing body of knowledge. After the Conference the information will be disseminated via the Internet and by scientific and popular publications.

Date and duration
Set for 30 & 31 March & 1 April 2005; to commence at 09:00 on the first day (30 March) and to end at 16:30 (1 April) the third day.

Format and scope of Conference
Alternating plenary, parallel sessions and debates focused on topical issues and interest groups. The Conference will strive to be maximally interactive and participative.

Themes and topics to cover:

Policy, management and health services/practice (various levels and contexts – clinical treatment, information, IT systems, pharmacy, laboratories, nutrition)
Research covering all relevant disciplines and diverse dimensions of ARV treatment and related themes
Training and evaluation of training
Patients, communities and civil society organisations
Public, private, NGO, FBO initiatives and partnerships

Emphasis will be on the Free State, however, with of significant involvement from other provinces, SADC countries, and countries further a field. The thrust will be to export lessons and experiences from the Free State, but also to import lessons and experiences from other provinces, countries and sectors.

Presenters
Key presenters from the Free State, other provinces, South Africa, from the private, FBO and NGO sectors, and from several other countries

Delegates
About half of the delegates will be Free State stakeholders and role players (all levels and all contexts). The other half will be role players and stakeholders in the ARV and related fields from other provinces, the national level, and other countries, as well as from the private, public and non-governmental sectors.

Focused workshops
Provision will be made for half-a-day or one-day workshop initiatives on the third day (1 April 2005).

Enquiries
For more information please contact:

Prof Dingie van Rensburg
Centre for Health Systems Research & Development
University of the Free State
PO Box 339
Bloenfontein
SOUTH AFRICA
9300

Contact:
Carin van Vuuren
Conference Organiser
Centre for Health Systems Research & Development
University of the Free State
P.O.Box 339
Bloemfontein
South Africa
9300
Tel +27 (0) 51 401 2181
Fax +27 (0) 51 4480370
Cell 0832932890
e-mail: arvconference.hum@mail.uovs.ac.za

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept